tenk.fyi

Taysha Gene Therapies, Inc.

TSHANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$8.3M

46.1% YoY

Net Income

-$89.3M

20.0% YoY

EPS

$-0.36

62.5% YoY

Cash

$139.0M

3.4% YoY

FY 2024 · As of 2024-12-31